The estimated effect of reducing the maternal smoking rate on neonatal intensive care unit costs in Victorian public hospitals

McCaffrey, Nikki; Dowling, Grace; White, S. L.

doi:10.1071/ah20277

Cited by 2 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…18 19 There is a substantial body of evidence on the longterm costs and benefits of TDT [20][21][22][23] but the health and economic benefits of routinely providing smoking cessation in the shorter term are less well known. A recent cost analysis suggests, all else being equal, reducing the 2016 maternal smoking rate from 8.4% to 6.4% could have saved 106 Victorian public hospital neonatal intensive care cot-days ($A276 000) 24 in 1 year. Further, 3580 (95% uncertainty interval (UI) 2312 to 5178) SSIs could have been prevented, and 8985 (95% UI 4094 to 19 153) hospital bed-days and $A19.1M (95% UI $A7.7M to $A42.5M) saved in Australia if the 2016 surgical smoking rate had reduced from 23.9% to 10%.…”

Section: Open Accessmentioning

confidence: 99%

Protocol for a systematic review of economic evaluations of preoperative smoking cessation interventions for preventing surgical complications

2021

Self Cite

View full text Add to dashboard Cite

IntroductionThe short-term economic benefit of embedding best practice tobacco dependence treatment (TDT) into healthcare services prior to surgery across different populations and jurisdictions is largely unknown. The aim of this systematic review is to summarise the cost-effectiveness of preoperative smoking cessation interventions for preventing surgical complications compared with usual care. The results will provide hospital managers, clinicians, healthcare professionals and policymakers with a critical summary of the economic evidence on providing TDT routinely before surgery, aiding the development and dissemination of unified, best practice guidelines, that is, implementation of article 14 of the WHO Framework Convention on Tobacco Control.Methods and analysisA comprehensive search of peer-reviewed literature will be conducted from database inception until 23 June 2021 (Cochrane, Econlit, Embase, Health Technology Assessment, Medline Complete, Scopus). Published, English-language articles describing economic evaluations of preoperative smoking cessation interventions for preventing surgical complications will be included. One researcher will complete the searches and two researchers will independently screen results for eligible studies. Any disagreement will be resolved by the third researcher. A narrative summary of included studies will be provided. Study characteristics, economic evaluation methods and cost-effectiveness results will be extracted by one reviewer and descriptive analyses will be undertaken. A second reviewer will review data extracted for accuracy from 10% of the included studies. Reporting and methodological quality of the included studies will be evaluated independently by two reviewers using the Consolidated Health Economic Evaluation Reporting Standards statement and the Quality of Health Economic Studies Instrument checklist, respectively.Ethics and disseminationThis research does not require ethics approval because the study is a planned systematic review of published literature. Findings will be presented at health economic, public health and tobacco control conferences, published in a peer-reviewed journal and disseminated via social media.Trial registration numberCRD42021257740.

show abstract

Section: Open Accessmentioning

confidence: 99%

Protocol for a systematic review of economic evaluations of preoperative smoking cessation interventions for preventing surgical complications

2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…These analyses typically estimate reductions in the prevalence and incidence of chronic diseases such as coronary heart disease and cancers due to reductions in the smoking rate through quitting and reduced uptake [ 7 , 8 ]. However, few population level, economic analyses consider the shorter term costs and benefits of smoking cessation, such as improvements in perinatal and neonatal outcomes [ 9 ] and reductions in post-operative complications [ 10 ].…”

Section: Introductionmentioning

confidence: 99%

What is the likely impact on surgical site infections in Australian hospitals if smoking rates are reduced? A cost analysis

et al. 2021

Self Cite

View full text Add to dashboard Cite

Introduction Assisting smokers to quit before surgery reduces surgical site infection (SSI) risk. The short-term economic benefits of reducing SSIs by embedding tobacco dependence treatment in Australian hospitals are unknown. Estimated annual number of SSIs prevented, and hospital bed-days (HBD) and costs saved from reducing smoking before surgery are calculated. Methods The most recent number of surgical procedures and SSI rates for Australia were sourced. The number of smokers and non-smokers having a SSI were calculated using the UK Royal College of Physicians reported adjusted odds ratio (1.79), and the proportion of SSIs attributable to smoking calculated. The potential impact fraction was used to estimate reductions in SSIs and associated HBDs and costs from reducing the smoking rates among surgical patients from 23.9% to 10% or 5% targets. Uncertainty around the final estimates was calculated using probabilistic sensitivity analysis. Results In 2016–17, approximately 40,593 (95% UI 32,543, 50,239) people having a surgical procedure in Australia experienced a SSI leading to 101,888 extra days (95% UI 49,988, 200,822) in hospital. If the smoking rate among surgical patients was reduced to 10%, 3,580 (95% UI 2,312, 5,178) SSIs would be prevented, and 8,985 (95% UI 4,094, 19,153) HBDs and $19.1M (95% UI $7.7M, $42.5M) saved in one year. If the smoking rate was reduced to 5%, 4,867 (95% UI 3,268, 6,867) SSIs would be prevented, and 12,217 (95% UI 5,614, 25,642) HBDs and $26.0M (95% UI $10.8M, $57.0M) would be saved. Conclusions The findings suggest achieving smoking rate targets of 10% or 5% would provide substantial short-term health and economic benefits through reductions in SSIs. Embedding tobacco dependence treatment in Australian hospitals would provide value for money by reducing costs and improving clinical quality and safety. A more comprehensive, modelled economic evaluation synthesising the best available evidence is needed to confirm findings.

show abstract

The estimated effect of reducing the maternal smoking rate on neonatal intensive care unit costs in Victorian public hospitals

Cited by 2 publications

References 3 publications

Protocol for a systematic review of economic evaluations of preoperative smoking cessation interventions for preventing surgical complications

Protocol for a systematic review of economic evaluations of preoperative smoking cessation interventions for preventing surgical complications

What is the likely impact on surgical site infections in Australian hospitals if smoking rates are reduced? A cost analysis

Contact Info

Product

Resources

About